How have BIS shares performed in 2024?

ProShares UltraShort Nasdaq Biotechnology's stock was trading at $18.07 on January 1st, 2024. Since then, BIS shares have increased by 16.1% and is now trading at $20.98. View the best growth stocks for 2024 here .

Are investors shorting ProShares UltraShort Nasdaq Biotechnology?

ProShares UltraShort Nasdaq Biotechnology saw a increase in short interest in March. As of March 31st, there was short interest totaling 19,300 shares, an increase of 144.3% from the March 15th total of 7,900 shares. Based on an average daily trading volume, of 23,300 shares, the short-interest ratio is presently 0.8 days. View ProShares UltraShort Nasdaq Biotechnology's Short Interest .

How often does ProShares UltraShort Nasdaq Biotechnology pay dividends? What is the dividend yield for ProShares UltraShort Nasdaq Biotechnology?

ProShares UltraShort Nasdaq Biotechnology declared a dividend on Tuesday, March 19th. Investors of record on Thursday, March 21st will be given a dividend of $0.1586 per share on Wednesday, March 27th. The ex-dividend date is Wednesday, March 20th. Read our dividend analysis for BIS .

What does BIS invest in?

ProShares UltraShort Nasdaq Biotechnology is a equity fund issued by ProShares. BIS focuses on health care investments and follows the Nasdaq Biotech Index. The fund's investments total to approximately $4.54 million assets under management.

What is the management fee for ProShares UltraShort Nasdaq Biotechnology?

ProShares UltraShort Nasdaq Biotechnology's management fee is 0.75% and has other expenses of 0.80%. However, BIS has a fee waiver of -0.60% to reimburse the expenses. The net expense ratio for BIS is 0.95%.

When did ProShares UltraShort Nasdaq Biotechnology's stock split?

ProShares UltraShort Nasdaq Biotechnology's stock reverse split before market open on Tuesday, August 18th 2020. The 1-4 reverse split was announced on Tuesday, August 4th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 17th 2020. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

What other stocks do shareholders of ProShares UltraShort Nasdaq Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares UltraShort Nasdaq Biotechnology investors own include Inovio Pharmaceuticals (INO) , Gilead Sciences (GILD) , Intel (INTC) , Quest Diagnostics (DGX) , Micron Technology (MU) , Pfizer (PFE) , Cidara Therapeutics (CDTX) and Vertex Pharmaceuticals (VRTX) .

Who are ProShares UltraShort Nasdaq Biotechnology's major shareholders?

ProShares UltraShort Nasdaq Biotechnology's stock is owned by a number of retail and institutional investors. Top institutional investors include IMC Chicago LLC (11.46%). View institutional ownership trends .

How do I buy shares of ProShares UltraShort Nasdaq Biotechnology?

Shares of BIS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:BIS

ProShares UltraShort Nasdaq Biotechnology (BIS) Price, Holdings, & News

→ Now Open: Crypto emergency update (From InvestorPlace) (Ad)

Free BIS Stock Alerts

$20.98

+0.41 (+1.99%)

(As of 04/18/2024 ET)

Compare

Today's Range: $20.54
▼
$20.98
50-Day Range: $16.46
▼
$20.98
52-Week Range: $16.37
▼
$26.51

Volume: 9,433 shs
Average Volume: 21,576 shs
Market Capitalization: $4.62 million

Assets Under Management: $4.54 million
Dividend Yield: 2.24%
Net Expense Ratio: 0.95%

Stock Analysis Chart Dividend Holdings Options Chain Ownership Short Interest Social Media

Get ProShares UltraShort Nasdaq Biotechnology alerts:

About ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in equity securities and derivatives that have similar daily performance characteristics as twice (200%) the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.

BIS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BIS ETF News Headlines

April 13, 2024 | americanbankingnews.com

Short Interest in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Expands By 144.3%

March 31, 2024 | msn.com

Compare with ProShares Ultra Nasdaq Biotechnology (BIB)

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

March 22, 2024 | msn.com

UltraShort Nasdaq Biotechnology declares quarterly distribution of $0.1586

January 31, 2024 | investing.com

ProShares UltraShort Nasdaq Biotechnology (BIS)

October 1, 2023 | benzinga.com

ProShares UltraPro QQQ (NASDAQ:TQQQ), Short Interest Report

May 13, 2023 | morningstar.com

ProFunds UltraShort NASDAQ-100 Svc

May 9, 2023 | marketwatch.com

Trading Proshares Ultrashort S&p500 $SDS With Integrated Risk Controls

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

March 12, 2023 | morningstar.com

ProFunds UltraShort NASDAQ-100 Inv

See More Headlines

Receive BIS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProShares UltraShort Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer: ProShares
Fund Name: ProShares UltraShort Nasdaq Biotechnology
Tax Classification: Regulated Investment Company
Stock Exchange: NASDAQ
Current Symbol: NASDAQ:BIS
Inception Date: 4/6/2010
Fund Manager: Michael Neches, Tarak Dave
Web: www.proshares.com
Phone: +1-240-4976400

Fund Focus

Asset Class: Equity
Benchmark: Nasdaq Biotech Index
Category: Sector
Focus: Health Care
Development Level: Developed Markets
Region: North America
Number of Holdings: 15

Fund Statistics

Assets Under Management: $4.54 million
Average Daily Volume: $9,267.80
Discount/Premium: 0.02%
Leveraged: -2.00

Administrator, Advisor and Custodian

Administrator: J.P. Morgan Investor Services Co.
Advisor: ProShare Advisors LLC
Custodian: JPMorgan Chase Bank, N.A.
Distributor: SEI Investments Distribution Co.
Transfer Agent: JPMorgan Chase Bank, N.A.
Trustee: N/A
Lead Market Maker: Virtu Financial

Options

Optionable: N/A
Short Interest: 19,300 shs

Miscellaneous

Outstanding Shares: 220,000
Beta: -1.41
Creation Unit: 50,000
Creation Fee: $250.00

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Ad InvestorPlace

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

ProShares UltraShort Nasdaq Biotechnology Expenses

Type	BIS	Health Care ETFs	Equity ETFs	NASDAQ ETFs	All ETFs
Management Fee	0.75%	0.56%	0.54%	0.48%	0.51%
Other Expenses	0.80%	0.40%	0.54%	0.34%	0.58%
Total Expense	1.55%	0.72%	0.70%	0.58%	0.70%
Fee Waiver	-0.60%	-0.53%	-0.55%	-0.22%	-0.57%
Net Expense	0.95%	0.60%	0.60%	0.54%	0.58%

ProShares UltraShort Nasdaq Biotechnology (BIS) Holdings

Top 7 BIS Holdings

NET OTHER ASSETS (LIABILITIES)
Holding Weight: 0.00%
NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG
Holding Weight: -4.40%
NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC
Holding Weight: -20.60%
NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA
Holding Weight: -30.11%
NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA
Holding Weight: -31.76%
NASDAQ BIO INDEX SWAP BNP
Holding Weight: -34.51%
NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE
Holding Weight: -78.77%

Full Holdings Details

Similar ETFs

Institutional Ownership

View All Institutional Transactions

BIS ETF - Frequently Asked Questions

How have BIS shares performed in 2024?: ProShares UltraShort Nasdaq Biotechnology's stock was trading at $18.07 on January 1st, 2024. Since then, BIS shares have increased by 16.1% and is now trading at $20.98.
View the best growth stocks for 2024 here.
Are investors shorting ProShares UltraShort Nasdaq Biotechnology?: ProShares UltraShort Nasdaq Biotechnology saw a increase in short interest in March. As of March 31st, there was short interest totaling 19,300 shares, an increase of 144.3% from the March 15th total of 7,900 shares. Based on an average daily trading volume, of 23,300 shares, the short-interest ratio is presently 0.8 days.
View ProShares UltraShort Nasdaq Biotechnology's Short Interest.
How often does ProShares UltraShort Nasdaq Biotechnology pay dividends? What is the dividend yield for ProShares UltraShort Nasdaq Biotechnology?: ProShares UltraShort Nasdaq Biotechnology declared a dividend on Tuesday, March 19th. Investors of record on Thursday, March 21st will be given a dividend of $0.1586 per share on Wednesday, March 27th. The ex-dividend date is Wednesday, March 20th.
Read our dividend analysis for BIS.
What does BIS invest in?: ProShares UltraShort Nasdaq Biotechnology is a equity fund issued by ProShares. BIS focuses on health care investments and follows the Nasdaq Biotech Index. The fund's investments total to approximately $4.54 million assets under management.
What is the management fee for ProShares UltraShort Nasdaq Biotechnology?: ProShares UltraShort Nasdaq Biotechnology's management fee is 0.75% and has other expenses of 0.80%. However, BIS has a fee waiver of -0.60% to reimburse the expenses. The net expense ratio for BIS is 0.95%.

When did ProShares UltraShort Nasdaq Biotechnology's stock split?: ProShares UltraShort Nasdaq Biotechnology's stock reverse split before market open on Tuesday, August 18th 2020. The 1-4 reverse split was announced on Tuesday, August 4th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 17th 2020. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.
What other stocks do shareholders of ProShares UltraShort Nasdaq Biotechnology own?: Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares UltraShort Nasdaq Biotechnology investors own include Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), Intel (INTC), Quest Diagnostics (DGX), Micron Technology (MU), Pfizer (PFE), Cidara Therapeutics (CDTX) and Vertex Pharmaceuticals (VRTX).
Who are ProShares UltraShort Nasdaq Biotechnology's major shareholders?: ProShares UltraShort Nasdaq Biotechnology's stock is owned by a number of retail and institutional investors. Top institutional investors include IMC Chicago LLC (11.46%).
View institutional ownership trends.
How do I buy shares of ProShares UltraShort Nasdaq Biotechnology?: Shares of BIS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BIS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial